2004•Shenyang Yaoke Daxue xuebaoRequires access

Evaluation of the pharmacokinetics of dexibuprofen modified-release capsules in Beagle dog

Gong Ai-shen

Open publisher page 0 citations

Abstract

Objective To develop a rapid and specific HPLC-UV method for the determination of dexibuprofen in Beagle dog plasma,and use it to investigate the pharmacokinetics of dexibuprofen in Beagle dog plasma.Method A single dose,two periods,cross-over study in 8 Beagle dogs was carried out.After an oral dose of dexibuprofen modified-release capsules (test) or Qingfen tablets (reference),the plasma samples were drawn and analyzed.Results There were no significant difference in AUC 0-t and AUC 0-∞ between the two preparations,but ρ max of the test preparation was less than the reference one and t max was obviously larger than it.Conclusion The release of the test preparation dexibuprofen modified-release capsules is modified.

About this research paper

What this paper is about

Objective To develop a rapid and specific HPLC-UV method for the determination of dexibuprofen in Beagle dog plasma,and use it to investigate the pharmacokinetics of dexibuprofen in Beagle dog plasma.Method A single dose,two periods,cross-over study in 8 Beagle dogs was carried out.After an oral dose of dexibuprofen modified-release capsules (test) or Qingfen tablets (reference),the plasma samples were drawn and analyzed.Results There were no significant difference in AUC 0-t and AUC 0-∞ between the two preparations,but ρ max of the test preparation was less than the reference one and t max was obviously larger than it.Conclusion The release of the test preparation dexibuprofen modified-release capsules is modified.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To develop a rapid and specific HPLC-UV method for the determination of dexibuprofen in Beagle dog plasma,and use it to investigate the pharmacokinetics of dexibuprofen in Beagle dog plasma.Method A single dose,two periods,cross-over study in 8 Beagle dogs was carried out.After an oral dose of dexibuprofen modified-release capsules (test) or Qingfen tablets (reference),the plasma samples were drawn and analyzed.Results There were no significant difference in AUC 0-t and AUC 0-∞ between the two preparations,but ρ max of the test preparation was less than the reference one and t max was obviously larger than it.Conclusion The release of the test preparation dexibuprofen modified-release capsules is modified.

Key concepts: Beagle, Pharmacokinetics, Plasma concentration, Chemistry, Pharmacology, Significant difference, Chromatography, Plasma levels

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation of the pharmacokinetics of dexibuprofen modified-release capsules in Beagle dog — Research Paper | ScholarLens